58 Leaders from 40 Political Parties attended Meeting (See 'Corp Brief') Odisha's New Coastal Highway: A Gateway to Spiritual Journeys (See 'Corp Brief') IBC - Foreign subsidiary assets must remain separate from parent company's insolvency proceedings: NCLAT (See 'Legal Desk') Vaishnaw flags Off Ramnagar-Dehradun Express (See 'Corp Brief') Centre provides extended Relief Window for Select Solar Projects up to December (See 'Corp Brief') Arbitration and Conciliation - A supervisory court lacks power to modify an award or grant fresh substantive reliefs, rendering petitioner's prayer for active domain transfer legally unmaintainable: HC (See 'Legal Desk') Vivek Nishant Nath takes charge as Director (Commercial), NMDC (See 'Corp Brief') Aadhaar App crosses 40 Million Downloads, Driving Convenient Digital Identity Services (See 'Corp Brief') Arbitration - Scope of interference under Section 37 of the Act is highly circumscribed & does not permit re-appreciation of evidence or fresh factual determination on matters of accounting: HC (See 'Legal Desk') PM lays bricks for 150-bed state-of-the-art Critical Care Block at PGIMER (See 'Corp Brief') Govt to release Revised Index of Core Industries Series with Base Year 2022-23 (See 'Corp Brief') 4th Edition of IICA's National Conference on Responsible Business Conduct held in Delhi (See 'Corp Brief') MSDE extends Special Intervention under PM-NAPS to Boost Apprenticeship (See 'Corp Brief') Centre for Trade and Investment Law launches guidebook to help Indian MSMEs expand into global markets (See 'Corp Brief') Capital Market - AMC/ Fund houses cannot, on grounds of commercial expediency or investor benefit, unilaterally extend maturity of securities and delay redemption of scheme proceeds: SC (See 'Legal Desk') Goyal leads High-Level Delegation to Finland to Strengthen Trade and Investment Ties (See 'Corp Brief') Over 75 Industries join ICAR CSR Conclave 2026 (See 'Corp Brief') Border infrastructure to remain indispensable in future technology-driven warfare: RM (See 'Corp Brief') ICMR study finds drone-enabled TB sample transport can reduce diagnosis time (See 'Corp Brief') Misc - Metro depot is indispensable part of metro rail project and therefore squarely falls within public purpose: SC (See 'Legal Desk') Atal Innovation Mission spearheads India's Frontier Innovation Push (See 'Corp Brief') CCI approves acquisition by Opal Bidco of 100% equity in STT GDC Pte. Ltd. (See 'Corp Brief') The Future belongs to those Who Learn, Adapt and Innovate: MoS (See 'Corp Brief') Misc - Inclusion of royalty, DMF and NMET in sale value under Mineral Conservation and Development Rules, 2017, is valid measure for computation of average sale price and does not alter nature of royalty u/s 9 of MMDR Act: SC (See 'Legal Desk') Bharat Tex 2026 Day 2 spotlights State Opportunities (See 'Corp Brief') 'Naye Bharat Ki Nayi Khadi': KVIC highlights innovation and contemporary design (See 'Corp Brief') IBC - Refund of court fees cannot be denied merely because dispute was resolved through CIRP framework rather than through formal court-referred process u/s 89 CPC: HC (See 'Legal Desk') IICA, DG Resettlement hold 5th Batch of Directors' Certification in Corporate Governance (See 'Corp Brief') DIBD, PNB sign MoU to advance Multilingual AI for Inclusive Banking (See 'Corp Brief') PMLA - Appellant cannot bypass strict statutory timelines of PMLA by filing defective appeal & allowing it to continue for seven months under guise of re-filing: HC (See 'Legal Desk') BRICS Nations adopt Landmark Declaration on Labour and Employment (See 'Corp Brief') India Mining Week 2026 to be held in November 15-17 (See 'Corp Brief') A&C - Debarment letter issued by AAI is administrative order arising from AAI's independent statutory and administrative powers, and not contractual measure under construction contract: HC (See 'Legal Desk') Cabinet approves two multitracking projects covering Four Districts across Odisha and Jharkhand (See 'Corp Brief') Ministry of Mines to launch 8th Tranche of Auction of Critical and Strategic Mineral Blocks (See 'Corp Brief') IPR - In copyright action involving logos, mere visual resemblance and prior adoption are not enough to justify interim relief, and reasonable possibility of access and prima facie causal link must be shown: HC (See 'Legal Desk') BIS hosts Heads of National Standardization Bodies of BRICS (See 'Corp Brief') Geo-spatial mapping of India-Myanmar border is in progress: MoS (See 'Corp Brief') Copyright - Purpose of proviso to Section 45(1) of Act is to maintain purity of register & prevent unscrupulous entities from evading trademark law by seeking shelter under false claims of copyright ownership over artistic work that mirrors another's registered trademark: HC (See 'Legal Desk') Bharat Tex 2026: Where India's Textile Vision meets the World's Trade Ambition (See 'Corp Brief') India Post records Highest-Ever Q1 Revenue of Rs.4,000 Crores (See 'Corp Brief') IPR - Confusion among consumers in pharmaceutical matters can be extremely detrimental, especially in relation to antibiotics: HC (See 'Legal Desk') NSFDC showcases success in bolstering entrepreneurship amongst depressed classes (See 'Corp Brief') Govt reviews BSNL performance for Q1 FY 2026-27 (See 'Corp Brief') India enters next phase of governance transformation with AI-driven administrative reforms: MoS (See 'Corp Brief') IPR - If infringing use is coupled alleged fraudulent online payment & earning schemes, conduct may be treated not merely as trademark infringement and passing off, but also as phishing & cyber fraud justifying urgent intervention: HC (See 'Legal Desk') MeitY releases 2nd edition of the Digital Threat Report 2025-26 for BFSI Sector (See 'Corp Brief') On Eve of Bharat Tex 2026, India prepares to host World's Largest Global Textiles Expo (See 'Corp Brief') IPR - In vitro screening method functions as diagnostic process, which is barred from patentability u/s 3(i) of Patents Act: HC (See 'Legal Desk') 'SANKALP' to guide CPWD's Journey towards Future-Ready Organisation: Union Minister (See 'Corp Brief') Healthcare facilities worth Rs 668 Crore to benefit 53 Lakh ESI Beneficiaries (See 'Corp Brief') Chouhan gives message of Green India during dialogue with Vriksh Mitra (See 'Corp Brief') IPR - If on visual comparison, rival medicinal marks are strikingly similar in essential features, overall get up and packaging, and where trade channels and consumer base are common, likelihood of deception is sufficient to justify interim injunction: HC (See 'Legal Desk') Lakhanpur among first towns selected under PM SVANidhi 'Street Food Hub' Plan: MoS (See 'Corp Brief') Paswan hails PMFME Scheme's landmark achievement of 2 lakh Credit-Linked Beneficiaries (See 'Corp Brief') 500 officials participate in inaugural webinar on Anemia and Adolescent Health (See 'Corp Brief') IPR - Purpose of summary judgment in commercial suits is to ensure time-bound disposal and that trial is not default norm: HC (See 'Legal Desk') Tech Innovation and disruption in Construction Industry (See 'CORP EINSICHT')

Print

Govt hosts workshop on increasing R&D in pharma-medical tech sector

Published: Mar 13, 2025

By TIOLCorplaws News Service

NEW DELHI, MAR 13, 2025: THE Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Government of India, organised a workshop on the Promotion of Research and Innovation in Pharma-MedTech Sector (PRIP) Scheme today. The workshop was inaugurated in the presence of the Secretaries of five stakeholder Ministries and Departments of the Government of India, namely, Amit Agrawal, Secretary, Department of Pharmaceuticals; Prof. Abhay Karandikar, Secretary, Department of Science and Technology (DST); S. Krishnan, Secretary, Ministry of Electronics and Information Technology (MeitY); Dr N. Kalaiselvi, Secretary, Department of Scientific and Industrial Research (DSIR) and Director General (DG), Council of Scientific and Industrial Research (CSIR); and Dr Rajiv Bahl, Secretary, Department of Health Research (DHR) and DG, Indian Council for Medical Research (ICMR). The workshop served as a platform for identifying key action points and approaches to further the shared commitment to promote research and development in the pharmaceuticals and medical technologies sector.

Amit Agrawal, Secretary, Department of Pharmaceuticals highlighted the rapid expansion in the sector, underscoring the importance of research and innovation in driving making and innovating in India for India and the world. In this regard, he highlighted that the global share of personalised and precision technology platforms (such as antibody-drug conjugates, bi-specific antibodies, and cell and gene therapy) among the top-100 drugs by value is growing rapidly, from 5% in 2020 to 9% in 2025 and projected to grow to 20% by 2030. He also highlighted the 10 times increase in the number of Indian healthcare and life sciences startups over the last four years, from over 900 in 2020 to more than 10,000 in 2024, as well as the growing pipeline of innovative products of Indian firms.

Amit Agrawal said that the groundwork and the pipeline for projects for the PRIP scheme has been laid through this growing innovation ecosystem of Indian startups and industry, supported by a wide array of initiatives of the scientific Ministries/ Departments. The latter include the clinical trial network created by CSIR under its INTENT initiative; the patenting support available through DST's TIFAC and ICMR's Patent Mitra initiative; the handholding support available to both medical technology and drug innovations through ICMR's MedTech Mitra initiative; the funding support available to startups through Department of Biotechnology's BIRAC, MeitY's TIDE 2.0 and SAMRIDH schemes and DST's Quantum Computing Mission, etc.

Reiterating the Government's commitment to a robust research ecosystem, Amit said that PRIP is a transformative initiative aimed at catalysing innovation, strengthening industry-academia linkages, and positioning India as a global leader in pharmaceutical and MedTech research.

Prof. Abhay Karandikar, Secretary, DST underscored the importance of cutting-edge scientific research in driving advancements in pharmaceuticals and MedTech, reinforcing India's healthcare ecosystem and highlighted the supports available through the extensive incubator and accelerator network of DST.

S. Krishnan, Secretary, MeitY emphasised the transformative potential of digital health, artificial intelligence (AI) and data-driven technologies in drug discovery and medical device development. He highlighted the research strengths of MeitY's organisations, such as Society for Applied Microwave Electronics Engineering and Research (SAMEER), C-DAC and Centre for Materials for Electronics Technology (C-MET).

Dr Rajiv Bahl, Secretary, DHR and DG, ICMR highlighted the critical role of clinical research, indigenous drug development and regulatory advancements in accelerating pharmaceutical innovation. He offered the full support of the ICMR INTENT, MedTech Mitra and Patent Mitra initiatives in taking forward the shared goals of PRIP scheme. He also said that the industry-academia collaborative research window under the scheme could be of considerable help in taking forward the large volume of intramural and extramural research being funded by ICMR to the market with funding from PRIP and industry involvement.

Dr N. Kalaiselvi, Secretary, DSIR and DG, CSIR underscored the need to foster a culture of scientific collaboration between research institutions and industry to ensure the seamless translation of research into commercially viable applications. She highlighted that considerable research done in CSIR labs could be taken to the market through collaboration with industry and funding from PRIP.

The discussions reaffirmed the Government's vision of transforming India into a global hub for research and innovation in pharmaceuticals and medical technology. The workshop featured four dedicated breakout sessions, bringing together over 100 participants from leading scientific departments and premier institutions, including the National Institutes of Pharmaceutical Education and Research, IITs, CSIR labs and organisations of ICMR, MeitY, DST and Department of Bio technology, along with key government enablers for the ecosystem. Key deliberations covered the emerging trends in pharmaceutical and MedTech research, strategies for translating research into commercially viable products, government support mechanisms to accelerate sectoral growth and flexibilities sought to maximise the impact from the PRIP scheme.

All participants were requested to share their suggestions in the Expression of Interest (EoI) form for the PRIP scheme hosted on the website of the Department of Pharmaceuticals, so that these may be taken into account while taking forward the scheme and enabling participants. The EoI would be open till April 7, 2025.

TIOL CORP SEARCH

TIOL GROUP WEBSITES

taxindiaonline
taxindiainternational
tioltube
TKF
TIOLawards
A TIOL Website. Copyright © 2025 TIOLcorplaws.com All rights reserved.